Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%

Pfizer, which currently holds a 32% stake in Haleon, said last May it planned to cut its ownership in a "slow and methodical" manner within months. The offer price per share is expected to be announced on or around March 19, following the completion of a book-building process, Haleon said in a statement. Haleon, which makes household brands such as Sensodyne toothpaste and Advil painkillers, was spun out of British drugmaker GSK in July 2022.